Results 301 to 310 of about 256,609 (339)

New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation.

JAMA cardiology, 2020
Importance Traditionally, physicians distinguished between mitral regurgitation (MR) as a determinant of outcomes and MR as a biomarker of left-ventricular (LV) dysfunction by designating the lesions as primary or secondary, respectively.
M. Packer, P. Grayburn
semanticscholar   +1 more source

Degenerative mitral regurgitation

Current Opinion in Cardiology, 2020
Purpose of review Degenerative mitral regurgitation (DMR) continues to be an important cause of morbidity and mortality with surgical mitral valve repair remaining the gold standard for the treatment of severe disease. The purpose of this review is to summarize recent advances in the understanding of DMR as well as the progress
Soulat-Dufour, Laurie, Addetia, Karima
openaire   +4 more sources

Secondary mitral regurgitation: pathophysiology, proportionality and prognosis

Heart, 2020
Secondary mitral regurgitation (SMR) occurs as a result of multifactorial left atrioventricular dysfunction and maleficent remodelling. It is the most common and undertreated form of mitral regurgitation (MR) and is associated with a very poor prognosis.
O. Chehab, R. Roberts-Thomson, Clarissa Ng Yin Ling, M. Marber, B. Prendergast, R. Rajani, S. Redwood   +6 more
semanticscholar   +1 more source

Quantitation of Mitral Regurgitation

Seminars in Thoracic and Cardiovascular Surgery, 2011
Mitral regurgitation (MR) is the most frequent valve disease. Nevertheless, evaluation of MR severity is difficult because standard color flow imaging is plagued by considerable pitfalls. Modern surgical indications in asymptomatic patients require precise assessment of MR severity.
Topilsky Y, GRIGIONI, FRANCESCO, Enriquez Sarano M.   +2 more
openaire   +4 more sources

An Appraisal of the Association of Clinical Outcomes With the Severity of Regurgitant Volume Relative to End-Diastolic Volume in Patients With Secondary Mitral Regurgitation.

JAMA cardiology, 2020
Importance Two randomized clinical trials of transcatheter edge-to-edge mitral valve repair in patients with secondary mitral regurgitation (the Multicentre Randomized Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe ...
W. Gaasch, G. Aurigemma, T. Meyer
semanticscholar   +1 more source

Functional mitral regurgitation

Current Opinion in Cardiology, 2020
Purpose of review Functional mitral regurgitation (FMR) is a complex condition in which significant mitral regurgitation coexist with cardiomyopathy and heart failure and carries an increased risk for associated morbidity and mortality.
Diego Medvedofsky, Federico M. Asch
openaire   +3 more sources

Mitral annular disjunction in patients with primary severe mitral regurgitation and mitral valve prolapse

Echocardiography, 2020
Mitral annular disjunction is a structural abnormality of the mitral annulus fibrosus which is often associated with mitral leaflet prolapse. However, few reports have described mitral annular disjunction in mitral valve prolapse (MVP).
T. Konda, T. Tani, Naoko Suganuma, Y. Fujii, M. Ota, T. Kitai, S. Kaji, Y. Furukawa   +7 more
semanticscholar   +1 more source

Degenerative mitral regurgitation

Nature Reviews Disease Primers, 2023
Degenerative mitral regurgitation is a major threat to public health and affects at least 24 million people worldwide, with an estimated 0.88 million disability-adjusted life years and 34,000 deaths in 2019. Improving access to diagnostic testing and to timely curative therapies such as surgical mitral valve repair will improve the outcomes of many ...
Victoria Delgado, Nina Ajmone Marsan, Robert O. Bonow, Rebecca T. Hahn, Russell A. Norris, Liesl Zühlke, Michael A. Borger   +6 more
openaire   +3 more sources

Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation.

New England Journal of Medicine
BACKGROUND Whether transcatheter mitral-valve repair improves outcomes in patients with heart failure and functional mitral regurgitation is uncertain.
Stefan D. Anker, T. Friede, R. V. von Bardeleben, Javed Butler, M. Khan, Monika Diek, Jutta Heinrich, Martin Geyer, Marius Placzek, Roberto Ferrari, William T. Abraham, Ottavio Alfieri, Angelo Auricchio, Antoni Bayés-Genís, J. Cleland, G. Filippatos, F. Gustafsson, Wilhelm Haverkamp, Malte Kelm, K. Kuck, Ulf Landmesser, A. P. Maggioni, M. Metra, Vlasis N. Ninios, Mark C Petrie, T. Rassaf, F. Ruschitzka, Ulrich Schäfer, P. C. Schulze, K. Spargias, A. Vahanian, J. Zamorano, A. Zeiher, Mahir Karakas, Friedrich Koehler, M. Lainščak, Alper Öner, N. Mezilis, E. Theofilogiannakos, Ilias Ninios, M. Chrissoheris, P. Kourkoveli, Konstantinos Papadopoulos, Grzegorz Smolka, Wojciech Wojakowski, Krzysztof Reczuch, Fausto J. Pinto, Łukasz Wiewiórka, Zbigniew Kalarus, M. Adamo, E. Santiago-Vacas, T. Ruf, Michael Gross, J. Tongers, Gerd Hasenfuß, Wolfgang Schillinger, P. Ponikowski   +56 more
semanticscholar   +1 more source

Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation.

New England Journal of Medicine
BACKGROUND Current treatment recommendations for patients with heart failure and secondary mitral regurgitation include transcatheter edge-to-edge repair and mitral-valve surgery.
S. Baldus, Torsten Doenst, Roman Pfister, Jan Gummert, M. Kessler, P. Boekstegers, Edith Lubos, Jörg Schröder, Holger Thiele, Thomas Walther, Malte Kelm, J. Hausleiter, Ingo Eitel, U. Fischer-Rasokat, Alexander Bufe, Alexander Schmeisser, Hüseyin Ince, P. Lurz, R. V. von Bardeleben, Christian Hagl, T. Noack, Sebastian Reith, H. Beucher, Hermann Reichenspurner, W. Rottbauer, P. C. Schulze, Wiebke Müller, Julia Frank, Martin Hellmich, T. Wahlers, V. Rudolph   +30 more
semanticscholar   +1 more source